Live AusBiotech updates | Page 3

Live AusBiotech news coverage of developments with the latest updates. Stay on top of latest AusBiotech news stories and find out what just happened, what is going on with AusBiotech. The latest real-time news updates and headlines on AusBiotech
Anteris Announces Positive 30-Day Trial Haemodynamic Results
Biotech headed to Hill for AusBiotech's Policy Forum
Alterity Therapeutics Unveils Fresh ATH434 Data
US FDA Awards Orphan Drug Status to Argenica's ARG-007
Neuren Pharma Wraps Up Phase 2 Trial for Phelan-McDermid Syndrome
University of Queensland Sets Up Global Leading mRNA Lab
Telix Initiates ProstACT Study with First Prostate Cancer Patient Dosed
Report Proves Long-Term Policy Commitment Benefits
Immutep Finishes Key Phase of AIPAC-003 Metastatic Cancer Trial
Clarity Hits Recruitment Goal for Phase II Prostate Cancer Trial
Imugene Announces Progress in Monotherapy, Combo Study Arms
Report Highlights Impact of R&D Tax Incentives on Aussie Economy
AusBiotech 2023 underway in Queensland
AusBiotech Board election result announced
AgTech Showcase kicks off month of innovation
New report quantifies impact of R&D Tax Incentive in Australia's life sciences sector
Australia's Largest Life Sciences Week Boosts Biotech
Emyria Gains Ethics Approval for MDMA Prescriber Application
Opthea Appoints US-Based Executives in Leadership Transition
AusBioInvest 2023 connects innovators with investment
WA Health and Life Sciences Receive Boost Ahead of AusBiotech 2023
AusBioInvest 2023 Kicks Off Australia's Largest Biotech Week
Imugene Begins Phase 1 Trial Using onCARlytics CD19 Virus Tech
Anteris Celebrates Positive Interim Results for DurAVR THV Trial
Top performing ASX life science companies 26 October
FDA Awards Orphan Drug Status to Certa's FT011 for Systemic Sclerosis
Immutep's Efti Proves Effective Combined with MSD's Pembrolizumab
AdAlta Sees Positive Patient Tolerance in AD-214 Study's 3rd Dose
AusBioInvest 2023 programme launched
Regional Nuclear Medicine Workforce Shortage Spurs Financial Aid
JP Morgan Investment Banking Chairman to Keynote AusBioInvest
Victoria Supports Australia's First Rare Genetic Disorder Stem Cell Trial
Prescient Reveals Phase 1b Cancer Trial Results at Top Haematology Meet
Prime Minister's Prizes Honor Australian Biotech, Science Pioneers
Oculus BioMed, Centre for Eye Research to Develop SwitchGene
Arovella Therapeutics Licenses Monoclonal Antibody for Cell Therapy
Posthumous recognition of benevolent billionaire
FivepHusion Appoints Seasoned Executive to Board
Training session on new Prescribed List products
CSL Unveils Seven New Global Research Acceleration Projects
FDA Awards Orphan Drug Status to Noxopharm's CRO-67
Dimerix, Advanz Pharma Ink Deal to Market DMX-200 Globally
Director appointed to Australia's Cell and Gene Catalyst
Amended Notice of AusBiotech's AGM 2023
Pharmaxis Transforms into Syntara Following Major Sale
Boost Your Company's Profile with Global Life Sciences Directory
National Team Progresses Innovative Biopolymer Particle Tech
Starpharma Presents DEP Irinotecan Combo Data